Exo® Acquires Medo Ai To Make Medical Imaging As Easy As Snapping A Smartphone Photo
Acquiring Company
Exo
Acquired Company
Medo AI
Redwood CityCommerce and ShoppingCommerce And ShoppingSportsDescription
Exo (pronounced “echo”), a pioneering health information and medical devices company, today announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s proprietary Sweep AITM technology into its ultrasound platform, Exo will make ultrasound imaging more accessible to a wider range of caregivers.
Who to call at Exo, and when
When Exo changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Exo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Exo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exo makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Medo AI?
Medo AI was acquired by Exo, based in Redwood City. The deal was reported on July 26, 2022. Exo is a health information and devices company. Exo believes everyone around the world should have access to high-quality, affordable and easy-to-use medical imaging. Exo is privately held and operates in Commerce and Shopping.
When did Exo acquire Medo AI?
Exo's acquisition of Medo AI was reported on July 26, 2022. Exo (pronounced “echo”), a pioneering health information and medical devices company, today announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medo AI do?
FDA-cleared AI platform that makes ultrasound workflow faster, more reliable and accessible to all. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.